Worldwide, an estimated 60 million people have epilepsy [1]. Approximately one-third of people with epilepsy (PWE) do not respond satisfactorily to antiepileptic drugs. When more than two combinations of antiepileptic drugs have been tried without satisfactory response, patients are considered to have drug-resistant epilepsy (DRE), which has a significant impact on their lives [2,3].
28
OCT
OCT
0